Background/Aims: Antituberculosis drug-induced liver injury (TB DILI) is a frequent medical
problem in Pakistan. Critical understanding of various aspects of TB DILI is not only …

Patients with tuberculosis (TB) disease treated with multi‐drug regimens are at risk of
developing drug induced liver injury (DILI), and DILI risk might be even higher in patients …

Introduction ATT remains the standard treatment for tuberculosis. Drug-induced liver injury
(DILI) has been a long-standing concern in the treatment of tuberculosis (TB) infection. Aims …

Background: Tuberculosis drug-induced liver injury (TB-DILI) is a common and potentially
severe adverse drug reaction leading to treatment interruption and treatment failure. The …

Background We describe drug-induced liver injury (DILI) secondary to antituberculous
treatment (ATT) in a large tuberculosis (TB) centre in London; we identify the proportion who …

Background Antituberculosis drug-induced liver injury (ATDILI) is a major safety concern for
the treatment of tuberculosis (TB). The impact of chronic hepatitis B infection (CHBI) on the …

Materials and Methods: Out of the cohort of 3900 tuberculosis patients who were initiated on
anti-tubercular therapy, 150 patients who developed drug-induced liver injury due to short …

Objective To analyze the clinical and laboratory characteristics and to identify predictors of
moderate to severe anti-tuberculosis drug-induced liver injury (ATB-DILI) in patients with …

Background There are limited data available on whether drug-induced hepatotoxicity (DIH)
affects the clinical outcomes of tuberculosis (TB) treatment. We explored the effects of DIH …

Drug-induced liver injury (DILI) due to anti-tubercular treatment (ATT) leads to increased
morbidity and mortality in patients with tuberculosis (TB). The aim of this study was to find the …